Eli Lilly and Company
New York Stock Exchange•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.Company Description
- CEO
- David A. Ricks
- Full Time Employees
- 47,000
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Address
- Lilly Corporate Center Indianapolis IN United States of America 46285
- IPO Date
- Jun 1, 1972
- CIK
- 0000059478
- Website
- lilly.com
- Similar Companies
- Business
- Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, Trajenta, and Trulicity for type 2 diabetes. The company provides Alimta for non-small cell lung cancer (NSCLC) and malignant pleural mesothelioma; Cyramza for metastatic gastric cancer, gastro-esophageal junction adenocarcinoma, metastatic NSCLC, metastatic colorectal cancer, and hepatocellular carcinoma; Erbitux for colorectal cancers, and various head and neck cancers; Retevmo for metastatic NSCLC, medullary thyroid cancer, and thyroid cancer; Tyvyt for relapsed or refractory classic Hodgkin's lymph and non-squamous NSCLC; and Verzenio for HR+, HER2- metastatic breast cancer, node positive, and early breast cancer. It offers Olumiant for rheumatoid arthritis; and Taltz for plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondylarthritis. The company offers Cymbalta for depressive disorder, diabetic peripheral neuropathic pain, generalized anxiety disorder, fibromyalgia, and chronic musculoskeletal pain; Emgality for migraine prevention and episodic cluster headache; and Zyprexa for schizophrenia, bipolar I disorder, and bipolar maintenance. Its Bamlanivimab and etesevimab, and Bebtelovimab for COVID-19; Cialis for erectile dysfunction and benign prostatic hyperplasia; and Forteo for osteoporosis. The company has collaborations with Incyte Corporation; Boehringer Ingelheim Pharmaceuticals, Inc.; AbCellera Biologics Inc.; Junshi Biosciences; Regor Therapeutics Group; Lycia Therapeutics, Inc.; Kumquat Biosciences Inc.; Entos Pharmaceuticals Inc.; and Foghorn Therapeutics Inc. Eli Lilly and Company was founded in 1876 and is headquartered in Indianapolis, Indiana.
Company News
Healthy Returns: Chinese obesity drug emerges as a potential rival to Eli Lilly's Zepbound
Eli Lilly (NYSE: LLY) Stock Price Prediction and Forecast 2025-2030 (July 2025)
Investors Heavily Search Eli Lilly and Company (LLY): Here is What You Need to Know
3 Dividend Growth Stocks to Buy and Hold
Orr: PLTR & NVDA are Overvalued, GOOGL & LLY Great Upcoming Picks
Can Mounjaro and Zepbound Drive Another Strong Quarter for Eli Lilly?
Eli Lilly Comes Out As ADA Winner
The Big 3: AVGO, LLY, UBER
Lilly Down More Than 15% in a Year: Time to Buy, Sell or Hold?
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
Eli Lilly (LLY) Beats Stock Market Upswing: What Investors Need to Know
Eli Lilly Q2 preview: BofA sees focus on policy risks, obesity pipeline
Zepbound Powers Eli Lilly's Upbeat Q2 Outlook
US FDA approves gradual dosing for Lilly Alzheimer's drug
FDA approves updated label for Lilly's Kisunla (donanemab-azbt) with new dosing in early symptomatic Alzheimer's disease
Don't Miss Out: 3 Blue-Chips Set to Pop This Earnings Season
Trump threatens impose up to 200% tariff on pharmaceuticals 'very soon'
3 Underrated Dividend Growth Stocks to Buy and Hold for Years
Demand for obesity drugs shoots up in India as Lilly, Novo jostle for market share
3 No-Brainer Stocks to Buy in July